Market Place
Sourcing Support
Lone Star Funds Announces Agreement To Acquire The Capsules &
06 Mar 2026 //
BUSSINESSWIRE
Lonza Achieves CHF 6.5B Sales In 2025, Reports Robust Profit
30 Jan 2026 //
INDPHARMAPOST
Lonza`s Synaffix, Sidewinder Ink Multi-Target ADC Deal
08 Jan 2026 //
PHARMIWEB
Microsize & Schedio Group Acquire Lonza`s Micro-Macinazione Site
24 Nov 2025 //
BUSINESSWIRE
Lonza To Acquire Redberry SAS
27 Oct 2025 //
CONTRACTPHARMA
Lonza Sales Rebound Continues With Boost From $1.2B Calif. Plant
23 Oct 2025 //
FIERCE PHARMA
Lonza Confirms Outlook as Expects More Contracts in Coming Months
23 Oct 2025 //
REUTERS
Lonza Names Jason Berndt Ops Head, Soler Nunez as Quality Chief
12 Sep 2025 //
PHARMAWEB
Lonza Records 19% H1 Sales Growth
23 Jul 2025 //
INDPHARMAPOST
Lonza appoints Andreas Bohrer as Chief Legal & Corporate Affairs
15 May 2025 //
CONTRACTPHARMA
Lonza partners with CMAC to boost drug product services
15 Apr 2025 //
INDPHARMAPOST
Lonza implements streamlined operating model
01 Apr 2025 //
INDPHARMAPOST
Lonza Delivers Solid 2024 Performance With 29.0% CORE EBITDA Margin
28 Jan 2025 //
PHARMAWEB
Strengthening APAC Presence Via Increased Penetration Key Focus
17 Jan 2025 //
EXPRESSPHARMA
Lonza expands Capsule Manufacturing Capacity in India and China
23 Dec 2024 //
EXPRESSPHARMA
Lonza To Exit Capsules Business, Focus On Contract Development
12 Dec 2024 //
REUTERS
Vertex adds CDMO Lonza to Casgevy production network
24 Sep 2024 //
FIERCE PHARMA
Lonza Launches Innovaform Accelerator CoE in France
19 Sep 2024 //
CONTRACT PHARMA
Lonza Upgrades Clinical Manufacturing Services at Bend Site
07 Aug 2024 //
CONTRACT PHARMA
Lonza Group Welcomes New CEO
02 Jul 2024 //
CONTRACT PHARMA
Lonza to Enhance Governance with Updates to its Board Committee Structure
24 Jun 2024 //
PRESS RELEASE
Annexon`s neurological disease drug succeeds in late-stage study
05 Jun 2024 //
REUTERS
Q1 2024 Qualitative:Performance In Line with Expectations for Full-Year 2024
13 May 2024 //
PHARMIWEB
Lonza Announces Results of the 2024 Annual General Meeting
08 May 2024 //
PHARMIWEB
Lonza Prices EUR 1 Billion Straight Bond with a 3.875% Coupon
17 Apr 2024 //
PRESS RELEASE
Lonza, NeuroSense Enter Alliance for ALS Candidate
09 Apr 2024 //
CONTRACTPHARMA
Lonza names Siegfried Holding boss as new CEO
02 Apr 2024 //
REUTERS
Lonza Expands Spray-Drying Services for Protein-Based Inhaled Therapies
27 Mar 2024 //
CONTRACT PHARMA
Epsilogen and Lonza Announce Successful Large-Scale GMP Manufacturing of MOv18
05 Mar 2024 //
BUSINESSWIRE
Lonza Delivers Solid 2023 Performance with 10.9% CER Sales Growth
26 Jan 2024 //
PRESS RELEASE
Jean-Marc Huët to succeed Albert M. Baehny as Chairman of Lonza
26 Jan 2024 //
PRESS RELEASE
Lonza chairman to step down, drugmaker confirms targets, shares soar
26 Jan 2024 //
REUTERS
Lonza closes plant in China but has a turnaround quarter
26 Jan 2024 //
FIERCE PHARMA
Lonza telegraphs hefty layoff round at California plant
17 Jan 2024 //
FIERCE PHARMA
NightHawk becomes pure-play CDMO; Lonza to make liver cancer drug
14 Dec 2023 //
ENDPTS
Medivir have agreed with Lonza to manufacture a fostrox GMP campaign
13 Dec 2023 //
PR NEWSWIRE
Exclusive: Manufacturer Lonza says it will not fill obesity drug syringes
17 Nov 2023 //
REUTERS
Lonza to add new filling line, 100 jobs at future Swiss site
16 Oct 2023 //
FIERCE PHARMA
Bluebird tweaks partnership with Lonza to boost Zynteglo
27 Sep 2023 //
ENDPTS
More leadership instability at Lonza as CEO Ruffieux steps down
18 Sep 2023 //
FIERCE PHARMA
Lonza launches new cell culture media system TheraPRO
18 Jul 2023 //
INDIAN PHARMA POST
Lonza launches TheraPEAK T-VIVO cell culture medium
24 May 2023 //
INDIAN PHARMA POST
Lonza Prices EUR 500 Million Straight Bond with a 3.875% Coupon
16 May 2023 //
PRESS RELEASE
Q1 Qualitative Update: Business Performance In Line With Full-Year Trajectory
10 May 2023 //
PRESS RELEASE
Lonza Announces Results of the 2023 Annual General Meeting
05 May 2023 //
PRESS RELEASE
Boehringer and Lonza question the future of FDA`s regulation of AI in Mfg
02 May 2023 //
ENDPTS
Lonza Increases Straight Bond by CHF 150 Million
20 Apr 2023 //
PHARMIWEB
Lonza Launches Share Buyback Program of up to CHF 2 Billion
31 Mar 2023 //
PRESS RELEASE
Lonza Completes Clinical, Commercial Drug Product Manufacturing Line in Visp
29 Mar 2023 //
CONTRACT PHARMA
Lonza Publishes Invitation to the 2023 Annual General Meeting
27 Mar 2023 //
PRESS RELEASE
Lonza Upgrades Powder Characterization Capabilities at Tampa Site
08 Mar 2023 //
CONTRACT PHARMA
Lonza Completes Expansion of Conjugation Facility in Visp
16 Feb 2023 //
CONTRACT PHARMA
Lonza opens lab as part of early development services expansion
14 Feb 2023 //
FIERCE PHARMA
Lonza breaks ground on $500M+ Swiss manufacturing facility
09 Feb 2023 //
ENDPTS
??Lonza Prices CHF 300 Million Straight Bond with a 2.100% Coupon?
08 Feb 2023 //
PRESS RELEASE
Lonza Breaks Ground on Commercial Drug Product Facility in Stein
01 Feb 2023 //
CONTRACT PHARMA
Lonza posts full 2022 results as it looks to buy back $2B+ in shares
25 Jan 2023 //
ENDPTS
Lonza collaborates Cristal Therapeutics & McSAF to expand Bioconjugates offering
18 Jan 2023 //
INDIANPHARMAPOST
Lonza Completes Expansion for Solid Form Services at Bend Site
17 Jan 2023 //
CONTRACT PHARMA
Context Therapeutics and Lonza Enter Manufacturing Agreement
09 Jan 2023 //
GLOBENEWSWIRE
